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A B S T R A C T
Object of research: the level of the Toll-like receptor type 9 expression on peripheral blood lym-
phocytes and monocytes in patients with measles of varying severity, both with and without com-
plications.
The solved problem: identification of the relationship between changes in the level of production 
of the main cytokines and virus-specific immunoglobulins and the level of expression of the Toll-
like receptor type 9 on immunocompetent peripheral blood cells of patients with measles infection 
of varying severity.
The main scientific results: In patients with measles infection have been identified three types of 
cytokine response, each of which is characterized by different levels of changes in the expression 
of the main cytokines, immunoglobulins, and their avidity. It was shown that the levels of expres-
sion of major cytokines and virus-specific antibodies, as well as their avidity, are associated with 
the level of expression of the Toll-like receptor type 9. It has been demonstrated that moderate 
disease is associated with a significant increase in the level of expression of the Toll-like receptor 
type 9 on the immunocompetent peripheral blood cells, while their low expression leads to the 
development of severe forms of the disease. It has been shown that in moderate disease the risk of 
complications is associated with a lower level of expression of the Toll-like receptor compared to 
the group without complications. In groups of patients with a severe course of the disease a signif-
icant decrease in the level of expression of the Toll-like receptor type 9 was shown to be associated 
with the risk of complications.
The field of practical use of the research results: medical institutions specializing in the treat-
ment of socially significant infectious diseases.
Innovative technological product: a method of advanced study of patients with and without 
measles infection of varying severity which allows to identify risk groups for the development of 
severe forms of the disease and complications, which in turn will allow the timely apply methods 
of immunomodulatory therapy and optimize the costs of the health system.
Scope of application of an innovative technological product: inpatient and outpatient treatment 
and diagnostics of patients with socially significant infectious diseases.
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1. Introduction
1. 1. The object of research
The object of research is the level of the Toll-like receptor type 9 expression on peripheral 
blood lymphocytes and monocytes in patients with measles of varying severity, both with and 
without complications.
1. 2. Problem description
Measles is a highly contagious viral infectious disease characterized by the development of 
general intoxication, fever, catarrhal syndrome, conjunctivitis and the development of a typical ex-
anthema. The persistence of the measles virus in the human body also leads to immunosuppression 
which in turn is a prerequisite for a high susceptibility of the affected organism to the addition of 
various secondary pathogens [1–3].
One of the main complications of measles infection is the affection of the respiratory tract, 
namely out-of-hospital pneumonia which is the cause of high mortality among patients with mea-
sles [4, 5]. During the last measles outbreak, which was observed on the territory of Ukraine in 
2017–2019, high mortality rates were due not only to the action of the virus itself, but also to the 
addition of secondary bacterial flora and the development of out-of-hospital pneumonia, which 
against the background of immunosuppression caused by the direct action of the virus had a severe 
course even with the use of powerful antibacterial agents.
An important link in a macroorganism protection from pathogen penetration is the innate 
immune response which uses pattern recognition receptors (PRRs) to detect microorganisms in-
vased the human body. PRRs recognize endogenous and exogenous ligands, including pathogen-as-
sociated molecular patterns (PAMPs), which are chemical motifs expressed by microorganisms. 
The most fully characterized type of pattern recognition receptors which are important modulators 
of the innate immune response due to the ability to recognize microorganisms localized both in the 
intercellular space and inside cells, are Toll-like receptors (TLRs). TLRs are the class of pattern 
PRRs that detect microorganisms that have entered the human body by recognizing PAMPs. Once 
PAMPs are detected TLRs trigger a signal transmission cascade that leads to the production of 
inflammatory mediators. Toll-like receptors represent important modulators of the innate immune 
response since they are able to recognize microorganisms localized both in the intercellular space 
and inside cells. The fact that TLRs are widely represented in the body’s cells confirms their central 
role in potential pathogens recognition. Ligands for TLR are double-stranded RNA (dsRNA), sin-
gle-stranded RNA (ssRNA), viral and bacterial RNA or unmethylated CPG DNA motifs resulting 
from hydrolytic degradation of microorganisms [6, 7].
One of the most important TLRs is the Toll-like receptor type 9. Activation of this receptor 
expression and signal transmission with its involvement are important mechanisms for triggering 
an innate immune response which leads to the activation of various structures depending on the 
cell type. In cDC, pDC and macrophages TLR9 activate the signal transmission cascade culminat-
ing in the production of proinflammatory cytokines – TNFα, IL-6 and IL-12, and interferon (IFN) 
type 1 [8, 9]. TLR9 has also been shown to be important in protecting the body from lung tissue 
affection caused by S.Pneumoniae and S.aureus [10–13].
Previous studies on the involvement of TLR9 in signal transmission have shown that re-
ceptor activation occurs after their interaction with unmethylated CpG DNA. However, in-depth 
studies conducted in recent years demonstrate the critical importance of these receptors in the case 
of damage to the body by RNA-containing viruses.
Jiang J et al.in their study involving to HIV-1- exposed seronegative individuals, demon-
strated that levels of TLR9 expression and interferon-7 regulation factor were higher in the group 
of seronegative individuals exposed to HIV-1, indicating that increased expression of TLR9 path-
way molecules in monocytes may be involved in mediating these individuals ‘ resistance to HIV-
1. The authors also studied the levels of antiviral factors and chemokines associated with both the 
TLR9 pathway and HIV-1 infection/replication, and demonstrated that seronegative individuals 
exposed to HIV-1, compared with the control group of patients, show an increase in IFNα, MIP-
1A and MIP-1B in peripheral blood mononuclears at the level of mRNA and IFNβ, MIP-1A, 
MIP-1B and RANTES at the level of protein in plasma. Thus, the authors demonstrated that 
increased activity of the TLR9 pathway in monocytes/macrophages contributes to a decrease in 
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the susceptibility of monocytic dendritic cells to HIV-1 in seronegative individuals exposed to 
HIV-1 [14].
In addition, Yanyan Liao et all in the study of drug users demonstrated that a decrease in 
TLR9 expression and activity resulting from drug use is accompanied by a decrease in key factors 
and cytokines of the TLR9 pathway and contributes to HIV infection and its replication in macro-
phages [15].
1. 3. Suggested solution to the problem
Despite understanding the importance of TLR9 in activation of the innate immune response to 
pathogen penetration, the role of this receptor in protecting the body from socially significant diseases 
is poorly understood. That is why given the significant number of patients with measles infection who 
were treated in Kharkiv Regional Clinical Infectious Diseases Hospital (Ukraine), immunological 
disorders that were detected in these patients [16, 17], as well as a significant number of patients with 
bacterial complications from the respiratory tract, it was considered interesting to study the level of 
Toll-like receptor expression in this cohort of patients and establish a relationship between the level of 
its expression, the degree of immunological disorders and the presence of complications.
Aim of the research: to determine the dependence of the severity of measles infection and 
the risk of complications on changes in the activity of the Toll-like receptors type 9 expression on 
immunocompetent peripheral blood cells.
2. Materials and methods
The study included 65 patients diagnosed with measles who were treated in the Kharkiv Re-
gional Clinical Infectious Diseases Hospital (Ukraine) between 2017 and 2019. The inclusion criteria 
were the presence of measles of varying severity, both with and without complications. Patients were 
divided into 4 groups depending on the severity of the disease and the presence of complications. 
Group 1 included patients who had moderate diseases without complications and were treated in the 
general department (n=20); group 2 included patients with moderate measles who had complications 
in the form of out-of-hospital pneumonia and were treated in the general department (n=20); group 
3 included patients with severe measles who had no complications and were treated in the intensive 
care unit (n=16); group 4 included patients with severe measles who had complications in the form 
of out-of-hospital pneumonia and were treated in the intensive care unit (n=9). The average age of 
patients was 36.16±1.59 years, women – 48 %, men – 52 %. Patients were admitted to the hospital on 
5.18±0.15 day from the onset of the disease and 4.29±0.12 day from the appearance of the rash. The 
diagnosis was established on the basis of the presence of typical clinical signs of the disease (catarrhal 
and intoxication syndromes, eye damage syndrome, enanthema and exanthema syndrome with a 
typical stage of appearance and disappearance of rashes), data from objective, instrumental and labo-
ratory research methods, epidemiological data (contact with patients with an established diagnosis of 
measles). The presence of pneumonia was confirmed by chest X-ray. All patients reported receiving 
measles vaccination in childhood. The control group consisted of 20 voluntary donors who at the time 
of blood sampling did not have clinical signs of measles, did not have contact with measles patients 
and did not have exclusion criteria (the presence of concomitant acute and chronic diseases from var-
ious organs and systems, immunosuppressive and autoimmune diseases, taking immunosuppressive 
drugs, performing surgical interventions 6 months before hospitalization because of measles, giving 
birth 6 months before hospitalization because of measles). 
All voluntary donors reported having been vaccinated against measles in childhood and 
never had measles during their lifetime. During the study, the provisions of the Helsinki Decla-
ration of the World Medical Association, the ethical code of the doctor of Ukraine and informing 
the patient about the nature of the study were strictly observed. All patients involved in the study 
signed informed consent to participate in the study. Protocol No. 2 of the Commission on Biomed-
ical Ethics of V. N. Karazin Kharkiv National University of the Ministry of Science of Ukraine 
dated 10.04.2021.
On the day of admission to the hospital the level of expression of Toll-like receptor type 9 
in the leukocyte suspension was determined in all patients. The study was performed using Flow 
Cytometry using a set of TLR9 monoclonal antibodies (CD123+) (Germany) in accordance with the 
manufacturer’s instructions. Also, with the help of solid-phase enzyme-linked immunosorbent assay 
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method the concentration in the blood serum of pro-and anti-inflammatory cytokines (IL-1, IL-6, 
IL-4, IL-10), IFNα and IFNγ as well as the level of virus-specific IgM, IgA and IgG with the level of 
avidity of the latter were determined using test systems manufactured by JSC “Vector-best” (Russian 
Federation), “Hema” (Ukraine), “The Native Antigen Company” (USA) according to the manufactur-
er’s instructions. A correlation analysis between the expression of Toll-like recetors and serum con-
centrations of pro- and anti- inflammatory cytokines as well as IFNα and IFNγ was also performed. 
Statistical processing of the obtained data was performed using the IBM SPSS Statistics 
22.0 program. The data in the tables are presented as the arithmetic mean (M)±average error 
of the arithmetic mean (m). When interpreting the significance of the difference in results, the 
Mann-Whitney criterion was used, and p<0.05 was considered the critical value of the significance 
level. When performing correlation-regression analysis, the Pearson correlation coefficient (critical 
value of the Student’s coefficient p<0.05) was used.
3. Research results
The study of the levels of pro- and anti-inflammatory cytokines and INFα and INFγ in the 
blood serum on the day of admission to the hospital showed an increase in them in all groups of 
patients compared with the control group. In patients of group 1 the level of IL-1 (CI: 45.1–154.6) 
and IL-6 (CI: 100.02–185.9) in the serum increased 3.9 times, INFα – 2.8 times (CI: 95.21–122.75), 
INFγ – 2.5 times (CI: 93.2–111.2), IL-4 and IL-10 – 3.7 times (CI: 80.91–104.89) and 3.6 times (CI: 
56.3–80.88). In patients of group 2 these indiced increased by 3.2 (CI: 61.6–101.8); 3.2 (CI: 84.6–
159.5); 2.4 (CI: 88.01–97.0); 1.7 (CI: 65.92–80.01); 3.0 (CI: 60.1–88.8); and 2.8 times (CI: 44.08–
62.12), respectively. In patients of group 3, the level of IL-1 increased 2.6 times (CI: 52.2–84.0), 
IL-6 – 1.9 times (CI: 55.1–86.3), INFα – 1.7 times (CI: 64.6–77.3), INFγ – 1.3 times (CI: 47.9–57.9), 
IL-4 – 1.4 times (CI: 26.9–46.7), IL- 10 – 1.1 times (CI: 16.6–25.9). In patients of group 4 – levels 
of IL-1, IL-6, IL-4 and IL-10 increased by 1.03 (CI: 21.3–31.44), 1.01 (CI: 17.4–56.6), 1.04 (CI: 
14.9–36.3) and 1.06 times (CI: 13.22–25.1), respectively; levels of INFα and INFγ in patients of this 












































Fig. 1. Cytokine profile in patients of groups 1-4 at the day of admission
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The study of the levels of specific IgG and IgA as well as IgG avidity on the day of admis-
sion to the hospital showed a decrease in their levels in relation to the control group in all groups 
of patients, while the lowest rates were recorded in patients of group 4 who had a severe course 
of the disease and the development of pneumonia. In comparison with the indices of individuals 
of the control group. In patients of group 1 the level of IgA in patients was reduced by 1.13 times 
(CI: 0.04–0.26), IgG was reduced by 1.2 times (CI: 0.96–1.47), IgG avidity was reduced by 1.09 
times (CI: 83.98–88.7); in patients of group 2 the indices were reduced by 1.7 (CI: 0.06–0.13), 1.28 
(CI: 0.94–1.33) and 1.17 times (CI: 76.83–83.0), respectively. In patients of group 3 the level of IgA 
was reduced by 2.42 times (CI: 0.03–0.12), IgG was reduced by 1.75 times (0.61–1.07), IgG avidity 
was reduced by 1.37 times (CI: 65.26–71.81); in patients of group 4 the indices were reduced by 3.4 
(CI:0.02–0.07), 1.98 (CI: 0.59–1.12) and 1.76 times (CI: 50.15–58.94), respectively. Also in patients 
of all groups the presence of Ig class M which were absent in individuals of the control group was 






























Fig. 2. Levels of IgA, IgG, IgM in patients of groups 1–4 at the day of admission
Analysis of data obtained by studying the level of Toll-like receptor type 9 expression 
showed that in patients of groups 1 and 2 who had a normoreactive type of cytokine response 
and significantly higher levels of IgA and IgG, the level of TLR9 expression on peripheral blood 
mononuclears was higher than in people of the control group; in patients of group 1 the level of 
TLR9 expression was by 2.53 times (CI:1.44–2.82) , and in patients of group 2 by 1.96 times (CI: 
1.11–2.18) higher than in people of the control group. In patients of group 3 who had a dissociative 
type of cytokine response and a more significant, comparing to patients of groups 1 and 2, decrease 
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in IgA and IgG levels, the level of TLR9 expression was by 1.33 times (CI: 0.59–0.87) lower than 
in the control group. In patients of group 4 who had a hyporeactive type of cytokine response and 
a statistically significant decrease in IgA and IgG levels, the level of TLR9 expression was the 
lowest; in patients of this group the TLR9 expression index was by 1.35 times (CI: 0.53–0.70) lower 
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Avidity, %
Fig. 3. The IgG avidity in patients of groups 1-4 at the day of admission
Table 1
TLR9 expression levels, cytokine profile indices and specific immune response of patients of groups 1-4 at 



































































































































Note: * – p<0.05 between the indices of patients and the control group
4. Discussion
The study of the cytokine profile of measles patients revealed three types of cytokine 
response to the infectious process: normoreactive, dissociative, and hyporeactive. The normo-
reactive type of cytokine response was observed in patients of groups 1 and 2, in whom the 
disease had a moderate course and was characterized by a statistically significant (p<0.05) 
increase in the levels of pro- and anti-inflammatory cytokines and IFNs compared to indi-
viduals of the control group. In patients of group 3, in whom the disease had a severe course 
and was not accompanied by the development of complications, a dissociative type of cyto-
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kine response was detected, which was characterized by a significant increase in the levels of 
pro-inflammatory cytokines and low levels of anti-inflammatory cytokines, as well as IFNα 
and IFNγ. Patients of group 4 in whom the disease was severe and accompanied by the develop-
ment of pneumonia, had a hyporeactive type of cytokine response, which was characterized by 
low levels of pro- and anti-inflammatory cytokines, the concentrations of which were slightly 
higher than those of the control group, and interferons, the levels of which were lower than 
those of the control group. As indicated by D. Griffin [3], the interaction of measles birus hem-
agglutinin (H) with monocytes leads to the activation of IL-6 production, and the interaction 
of the measles virus with epithelial cells leads to an increase in the production of IL-8. In vivo 
studies also confirmed an increase in the level of IL-1 and IL-8 protein in the blood plasma of 
children infected with measles.
With regard to anti-inflammatory cytokines it was demonstrated that the production of 
Th cells type 1 which is observed at the initial stages of infection, in a later period is replaced 
by the production of type 2 cytokines – IL-4, IL-10 and IL-13 the increased levels of which are 
observed and after clinical recovery of patients [18].
The study found that measles in patients of groups 1–4 occurred against a background 
of low levels of specific antibodies. It is noteworthy that in patients of groups 3 and 4 the level 
of specific IgM on the day of hospitalization was high and significantly higher (p˂0.05) than 
in patients of groups 1 and 2, that can be considered as indirect evidence of the predominance 
of the immune system response to infection by primary type and ineffectiveness of conducted 
routine vaccination. These data confirm the data obtained by Brigitta Laksono et all [1] that 
demonstrated notional decrease of IgG+ and IgA+ memory B cells before and after measles. 
Also in children included in their study blood serum was negative for measles virus-specific 
IgG prior the infection and afer the infection become measles virus-specific IgG and IgM 
positive.
It is noteworthy that among patients with a normoreactive type of cytokine response in 
patients of group 2, in which the disease had a moderate course but was accompanied by the 
development of pneumonia, the increase in TLR9 expression was less significant, compared 
with patients of group 1, who had no complications. Also noteworthy is a significant decrease 
in the level of TLR9 expression in patients of group 4 who had a severe course of the disease 
with the development of extrahospital pneumonia. These data are consistent with the results 
of D.Parker and A. Prince [13] which showed better survival rates in S. aureus-infected mice 
Tlr9-/-compared to WT mice. 
A Pearson correlation analysis performed on the day of admission showed a direct cor-
relation between TLR9 expression levels and serum levels of IFNα, IFNγ, and pro-inflamma-
tory cytokines (IL-1 and IL-6). An inverse correlation was established with respect to anti-in-
f lammatory cytokines – interleukins 4 and 10.
In relation to IFNα, a direct high correlation was found in all study groups; the depen-
dence of the stadied traits in all groups was statistically significant (p<0.05). The correlation 
between TLR9 expression levels and IFNγ levels ranged from weak to noticeable; the depen-
dence of stadied traits in all groups was statistically significant (p<0.05). Determination of 
the correlation between the level of TLR9 expression and the level of IL-1 established a direct 
correlation between the indicess, while in patients of groups 1–3 the dependence of signs was 
statistically significant, and in patients of group 4 – statistically insignificant (p>0.05).
For anti-inflammatory cytokines – interleukin 4 and 10 – a negative correlation was 
found with the level of TLR9 expression. The statistical significance of the relationship be-
tween the studied indices in all groups was absent (p>0.05), and the strength of the relationship 
ranged from weak to high.
Study limitations. The study included adult patients with measles of verying severity 
(B05) according to the ICD 10 both with and without complications.
Prospects for further research. The study of an affection of TLR9 expression activity 
on immunocompetent cells of the peripheral blood can be used to better understand immune 
system disorders in patients with viral diseases as a predictor and possible factor in the sever-
ity of the disease and the development of complications.
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5. Conclusions
Measles infection of moderate severity, characterized by a normoreactive type of cy-
tokine response, significant increase in medium- and high-avidity antibodies and a reaction 
of the immune system by a secondary type, is associated with a significant activation of the 
TLR9 expression on immunocompetent peripheral blood cells.
A decrease in the level of TLR9 expression leads to the development of a severe course 
of the disease. At the same time, a 1.15-fold decrease is associated with the development of 
a hyporeactive type of cytokine response, a decrease in the level of virus-specific IgG and 
their avidity, but is not accompanied by the development of complications, while a 1.35-fold 
decrease in the level of TLR9 expression is associated with the development of a severe com-
plicated course of measles infection, a dissociative type of cytokine response, a significant 
decrease in the levels of virus-specific Igs, their low avidity and a reaction of the immune 
system by a primary type.
The level of the Toll-like receptor type 9 expression on immunocompetent peripheral 
blood cells of patients with measles infection can be considered as an important factor affect-
ing the state of the immune system and the strength of the immunological response in response 
to the penetration of the pathogen.
The study of the level of the Toll-like receptor type 9 expression will allow to identify 
groups at risk of severe forms of the disease and complications development, to timely apply 
methods of an immunomodulatory therapy in such groups of patients and, thereby, to optimize 
the costs of the health system.
Conflict of interests
The authors declare that they have no conflicts of interest.
References
[1] Laksono, B. M., de Vries, R. D., Verburgh, R. J., Visser, E. G., de Jong, A., Fraaij, P. L. A. et. al. (2018). Studies into the mecha-
nism of measles-associated immune suppression during a measles outbreak in the Netherlands. Nature Communications, 9 (1). 
doi: http://doi.org/10.1038/s41467-018-07515-0 
[2] De Vries, R. D., de Swart, R. L. (2014). Measles Immune Suppression: Functional Impairment or Numbers Game? PLoS Patho-
gens, 10 (12), e1004482. doi: http://doi.org/10.1371/journal.ppat.1004482 
[3] Laksono, B., de Vries, R., McQuaid, S., Duprex, W., de Swart, R. (2016). Measles Virus Host Invasion and Pathogenesis. Vi-
ruses, 8 (8), 210. doi: http://doi.org/10.3390/v8080210 
[4] Schoini, P., Karampitsakos, T., Avdikou, M., Athanasopoulou, A., Tsoukalas, G., Tzouvelekis, A. (2019). Measles pneumonitis. 
Advances in Respiratory Medicine, 87 (1), 63–67. doi: http://doi.org/10.5603/arm.a2019.0010 
[5] Li, J., Zhao, Y., Liu, Z., Zhang, T., Liu, C., Liu, X. (2015). Clinical report of serious complications associated with measles 
pneumonia in children hospitalized at Shengjing hospital, China. The Journal of Infection in Developing Countries, 9 (10), 
1139–1146. doi: http://doi.org/10.3855/jidc.6534 
[6] Kawasaki, T., Kawai, T. (2014). Toll-Like Receptor Signaling Pathways. Frontiers in Immunology, 5. doi: http://doi.org/10.3389/
fimmu.2014.00461 
[7] El-Zayat, S. R., Sibaii, H., Mannaa, F. A. (2019). Toll-like receptors activation, signaling, and targeting: an overview. Bulletin 
of the National Research Centre, 43 (1). doi: http://doi.org/10.1186/s42269-019-0227-2 
[8] Combes, A., Camosseto, V., N’Guessan, P., Argüello, R. J., Mussard, J., Caux, C. et. al. (2017). BAD-LAMP controls TLR9 
trafficking and signalling in human plasmacytoid dendritic cells. Nature Communications, 8 (1). doi: http://doi.org/10.1038/
s41467-017-00695-1 
[9] Martínez-Colón, G. J., Warheit-Niemi, H., Gurczynski, S. J., Taylor, Q. M., Wilke, C. A., Podsiad, A. B. et. al. (2019). Influen-
za-induced immune suppression to methicillin-resistant Staphylococcus aureus is mediated by TLR9. PLOS Pathogens, 15 (1), 
e1007560. doi: http://doi.org/10.1371/journal.ppat.1007560 
[10] Gahlot, S., Nasreen, N., Johnson, J. A., Sahn, S. A., Mohammed, K. A. (2017). Heme Oxygenase-1 Deficiency Diminishes 
Methicillin-Resistant Staphylococcus aureus Clearance Due to Reduced TLR9 Expression in Pleural Mesothelial Cells. PLOS 
ONE, 12 (1), e0169245. doi: http://doi.org/10.1371/journal.pone.0169245 
[11] Van der Meer, A. J., Achouiti, A., van der Ende, A., Soussan, A. A., Florquin, S., de Vos, A. et. al. (2016). Toll-Like Receptor 9 
Enhances Bacterial Clearance and Limits Lung Consolidation in Murine Pneumonia Caused by Methicillin-Resistant Staphy-
lococcus aureus. Molecular Medicine, 22 (1), 292–299. doi: http://doi.org/10.2119/molmed.2015.00242 
74
No. 2 (73), 2021ScienceRise  ISSN 2313-8416
[12] Zhang, S., Jia, X., Zhang, Q., Zhang, L., Yang, J., Hu, C. et. al. (2019). Neutrophil extracellular traps activate lung fibroblast 
to induce polymyositis‐related interstitial lung diseases via TLR9‐miR‐7‐Smad2 pathway. Journal of Cellular and Molecular 
Medicine, 24 (2), 1658–1669. doi: http://doi.org/10.1111/jcmm.14858 
[13] Parker, D., Prince, A. (2012). Staphylococcus aureus Induces Type I IFN Signaling in Dendritic Cells Via TLR9. The Journal 
of Immunology, 189 (8), 4040–4046. doi: http://doi.org/10.4049/jimmunol.1201055 
[14] Jiang, J., Hu, X., Li, W., Liu, J., Liang, B., Chen, H. et. al. (2020). Enhanced Signaling Through the TLR9 Pathway Is Associ-
ated With Resistance to HIV-1 Infection in Chinese HIV-1–Exposed Seronegative Individuals. Frontiers in Immunology, 11. 
doi: http://doi.org/10.3389/fimmu.2020.01050 
[15] Liao, Y., Jiang, J., Liang, B., Wei, F., Huang, J., Pan, P. et. al. (2017). Opiate use inhibits TLR9 signaling pathway in vivo: pos-
sible role in pathogenesis of HIV-1 infection. Scientific Reports, 7 (1). doi: http://doi.org/10.1038/s41598-017-12066-3 
[16] Veklych, K. A., Popov, M. M., Liadova, T. I., Sorokina, O. G. (2020). The nature of a specific immune response to measles 
infection of varying severity. Bulletin of Problems Biology and Medicine, 4 (1), 100–104. doi: http://doi.org/10.29254/ 
2077-4214-2020-4-158-100-104 
[17] Veklych, K. A., Popov, N. N., Liadova, T. I., Sorokina, O. G. (2020). Autoimmune markers in measles infection of varying 
severity. Actual Problems of the Modern Medicine: Bulletin of Ukrainian Medical Stomatological Academy, 20 (4), 11–16. doi: 
http://doi.org/10.31718/2077-1096.20.4.11 
[18] Marongiu, L., Gornati, L., Artuso, I., Zanoni, I., Granucci, F. (2019). Below the surface: The inner lives of TLR4 and TLR9. 
Journal of Leukocyte Biology, 106 (1), 147–160. doi: http://doi.org/10.1002/jlb.3mir1218-483rr 
